rs12722521

chr10-6036833-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BS1 BS2

The NM_000417.3(IL2RA):c.65-10808C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0382 in 152,212 control chromosomes in the GnomAD database, including 132 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.038 (132 hom., cov: 32)
• Consequence: IL2RA NM_000417.3 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.225

Genes affected

IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.92).
• BS1: Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0382 (5811/152212) while in subpopulation AFR AF= 0.0496 (2059/41530). AF 95% confidence interval is 0.0478. There are 132 homozygotes in gnomad4. There are 2734 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
• BS2: High Homozygotes in GnomAd at 133 AR gene

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
IL2RA	NM_000417.3	c.65-10808C>T		intron_variant		ENST00000379959.8
IL2RA	NM_001308242.2	c.65-10808C>T		intron_variant
IL2RA	NM_001308243.2	c.65-10808C>T		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
IL2RA	ENST00000379959.8	c.65-10808C>T		intron_variant		1	NM_000417.3	P1

Frequencies

GnomAD3 genomes AF: 0.0381 AC: 5799 AN: 152094 Hom.: 133 Cov.: 32

Gnomad AFR AF: 0.0494

Gnomad AMI AF: 0.00877

Gnomad AMR AF: 0.0371

Gnomad ASJ AF: 0.0804

Gnomad EAS AF: 0.000193

Gnomad SAS AF: 0.0307

Gnomad FIN AF: 0.0128

Gnomad MID AF: 0.127

Gnomad NFE AF: 0.0363

Gnomad OTH AF: 0.0509

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.0382 AC: 5811 AN: 152212 Hom.: 132 Cov.: 32 AF XY: 0.0367 AC XY: 2734 AN XY: 74416

Gnomad4 AFR AF: 0.0496

Gnomad4 AMR AF: 0.0371

Gnomad4 ASJ AF: 0.0804

Gnomad4 EAS AF: 0.000193

Gnomad4 SAS AF: 0.0311

Gnomad4 FIN AF: 0.0128

Gnomad4 NFE AF: 0.0362

Gnomad4 OTH AF: 0.0503

Alfa AF: 0.0364 Hom.: 32

Bravo AF: 0.0407

Asia WGS AF: 0.0180 AC: 62 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.92
Cadd	Benign	2.0
Dann	Benign	0.75

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs12722521; hg19: chr10-6078796;